Pharmacy and Pharmaceutical Sciences > News > Faculty & Student Scholarship > February 2025 Updates

February 2025 Updates

The Faculty and Student Scholarship section is provided as a service to the WSU College of Pharmacy and Pharmaceutical Sciences community for sharing publications, presentations, and other highly transactional types of information. Accuracy of the information presented is the responsibility of those who submitted it. Submissions are reviewed for compliance with state statutes and ethics guidelines but are not edited for spelling, grammar, or clarity. Submission for Pharmaceutical Sciences faculty and PhD students can be directed to Kami Ryplewski and submissions for Pharmacotherapy faculty and Doctor of Pharmacy students to Faith Townsend.

Faculty Scholarship

Publications

  • Rhee CM, Gianchandani RY, Kerr D, Philis-Tsimikas A, Kovesdy CP, Stanton RC, Drincic AT, Galindo RJ, Kalantar-Zadeh K, Neumiller JJ, de Boer IH, Lind M, Kim SH, Ayers AT, Ho CN, Aaaron RE, Tian T, Klonoff DC. Consensus report on the use of continuous glucose monitoring in chronic kidney disease and diabetes. J Diabetes Sci Technol 2024 Nov 29:19322968241292041. Online ahead of print.
  • Kimberly McKeirnan, Megan Giruzzi, Damianne Brand, Nick Giruzzi, and co-authors published, “Education for Healthcare Providers: Impact of Academic Detailing on Reducing Misinformation and Strengthening Influenza Vaccine Recommendations” in the December 2024 issue of Pharmacy.
  • Kim McKeirnan, Megan Undeberg, Sky Zelenko, and Ghazal Meratnia published an article “A Qualitative Analysis of Rural Community Vaccination Barriers During the COVID-19 Pandemic” in Vaccines as part of the Special Issue Infectious Diseases: Importance for Public Health, Epidemiology, Promoting Factors, and Vaccines Prevention
  • Levien TL, Baker DE. Respiratory syncytial virus vaccine (mRNA). Hospital Pharmacy. 2024; ePub ahead of print. November 2024. doi.org/10.1177/0018578724129814
  • Baker DE. Drug Evaluation – Sofpironium (Sofdra).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  November 2024.
  • Levien TL, Baker DE. Drug Evaluation – Deuruxolitinib (Leqselvi.  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  November 2024.
  • Baker DE. Drug Evaluation – Crovalimab (PiaSky).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  November 2024.
  • Moore TJ, Hitt EM, Levien TL, Baker DE. Drug Evaluation – Epinephrine Nasal Spray (Neffy).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  November 2024.
  • Hitt EM, Baker DE. Drug Evaluation – Ensifentrine (Oltuvayre).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  November 2024.
  • Baker DE. Drug Utilization Evaluation – Ensifentrine (Oltuvayre).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Clinical Drug Information, LLC.  November 2024.
  • Hitt EM, Baker DE. Drug Evaluation – Afamitresgene autoleucel (Tecelra).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  December 2024.
  • Levien TL, Baker DE. Drug Evaluation – Axatilimab (Niktimvo).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  December 2024.
  • Hitt EM, Baker DE. Drug Evaluation – Donanemab-azbt (Kisunla).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  December 2024.
  • Baker DE. Drug Evaluation – Palopegteriparatide (Yorvipath).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  December 2024.
  • Baker DE. Drug Evaluation – Seladelpar (Livdelzi).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  December 2024.
  • Baker DE. Drug Utilization Evaluation – Epinephrine Nasal Spray (Neffy).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Clinical Drug Information, LLC.  December 2024.
  • Hitt EM, Baker DE. Drug Evaluation – Vorasidenib (Varanigo).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  January 2025.
  • Baker DE. Drug Evaluation – Foscarbidopa/Foslevodopa (Vyalev).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  January 2025.
  • Levien TL, Baker DE. Drug Evaluation –. Lazertinib (Lazcluze)   In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  January 2025.
  • Levien TL, Baker DE. Drug Evaluation – Marstacimab-hncq (Hympavzi).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  January 2025.
  • Baker DE. Drug Evaluation –Nemolizumab (Nemluvio).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  January 2025.
  • Baker DE. Drug Utilization Evaluation – Foscarbidopa/Foslevodopa (Vyalev).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Clinical Drug Information, LLC.  January 2025.
  • Damianne Brand worked with a group to survey and publish Pharmacists’ perceptions of artificial intelligence: A national survey
  • Damianne Brand, with Megan Giruzzi, Kim McKiernan, and others to survey rural Yakima County and publish: Evaluating Factors That Influence Influenza Vaccination Uptake among Pregnant People in a Medically Underserved Area in Washington State
  •  Med Matters column in the Yakima Herald Republic newspaper with Angie Stwart educating the community about polypharmacy
  • McCoy RG, Swarna KS, Neumiller JJ, Polley EC, Deng Y, Mickelson MM, Herrin J. Risk of severe hypoglycemia after initiation of noninsulin glucose-lowering therapies in adults with type 2 diabetes at moderate cardiovascular disease risk. Clin Diabetes 2024;43(1):59-70.
  • USTUR Director and Professor Sergei Tolmachev with eighteen co-authors published book chapter, “A million persons, a million dreams: a vision,” for a National Center for Radiation Epidemiology and Biology. In: Boice JD, Bouville A, Dauer LT, Golden A, Wakeford R (Eds). The Million Person Study of the Low Dose Health Effects. London, UK: CRC Press; 327–355; 2024.
  • Sergei Tolmachev and USTUR Associate Professor Maia Avtandilashvili, with nine co-authors published book chapter, “Radium dial workers: back to the future.” In: Boice JD, Bouville A, Dauer LT, Golden A, Wakeford R (Eds). The Million Person Study of the Low Dose Health Effects. London, UK: CRC Press; 280–298; 2024.
  • Sergei Tolmachev and two co-authors published book chapter, “Potential improvements in brain dose estimates for internal emitters”, In: Boice JD, Bouville A, Dauer LT, Golden A, Wakeford R (Eds). The Million Person Study of the Low Dose Health Effects. London, UK: CRC Press; 125–138; 2024
  • Sergei Tolmachev, Eilzabeth M. Thomas (laboratory technician, USTUR), Maia Avtandilashvili, USTUR Associate Professor George Tabatadze, and nine co-authors published, “Distribution of plutonium and radium in the human heart.” Journal of Radiological Protection 44(4): 041515; 2024
  • Sergei Tolmachev and twenty-two co-authors published, “A Million Person Study innovation: Evaluating cognitive impairment and other morbidity outcomes from chronic radiation exposure through linkages with the centers for Medicaid and Medicare Services Assessment and Claims Data”, Radiation Research 202(6): 847–861; 2024.
  • Neumiller JJ, Bajaj M, Bannuru RR, McCoy RG, Pekas EJ, Segal AR, ElSayed NA. Compounded GLP 1 and dual GIP/GLP 1 receptor agonists: A statement from the American Diabetes Association. Diabetes Care 2024. Online ahead of print.

Presentations

  • Sergei Tolmachev presented a talk at The United States Transuranium and Uranium Registries: 55 years of experience in actinide research and radiochemical analysis at PNNL Radiochemistry Group’s Colloquium, Richland, WA, December 12, 2024.
  • Dammianne Brand APhA annual 2025 in March conference poster accepted: Patient trust in healthcare providers and their influenza vaccination recommendations and its impact on a rural community’s uptake of the vaccine.

Service

  • Josh Neumiller has joined the Editorial Board for the journal Pharmacotherapy.
  • Josh Neumiller has been elected 2025 President, Health Care & Education for the American Diabetes Association (ADA) and will serve on the ADA Board of Directors.